Skip to main content

CORRECTION article

Front. Mol. Biosci. , 07 May 2021

Sec. Molecular Diagnostics and Therapeutics

Volume 8 - 2021 | https://doi.org/10.3389/fmolb.2021.687587

Corrigendum: A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke

This article is a correction to:

  1. A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke

    1. Read original article
\nBrett A. Eyford,,,&#x;Brett A. Eyford1,2,3,4†Chaahat S. B. Singh,,,,&#x;Chaahat S. B. Singh1,2,3,4,5†Thomas Abraham&#x;Thomas Abraham6†Lonna Munro,Lonna Munro1,3Kyung Bok Choi,Kyung Bok Choi1,3Tracy HillTracy Hill7Rhonda HildebrandtRhonda Hildebrandt7Ian WelchIan Welch7Timothy Z. Vitalis,Timothy Z. Vitalis8,9Reinhard Gabathuler,Reinhard Gabathuler9,10Jacob A. Gordon,Jacob A. Gordon2,11Hans Adomat,Hans Adomat2,11Emma S.T. Guns,Emma S.T. Guns2,11Chieh-Ju Lu,,,Chieh-Ju Lu1,2,3,4Cheryl G. Pfeifer,,,Cheryl G. Pfeifer1,2,3,4Mei Mei TianMei Mei Tian9Wilfred A. Jefferies,,,,,,, Wilfred A. Jefferies1,2,3,4,5,11,12,13*
  • 1Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada
  • 2The Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada
  • 3Centre for Blood Research, University of British Columbia, Vancouver, BC, Canada
  • 4The Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada
  • 5Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
  • 6Department of Neural and Behavioral Sciences and Microscopy Imaging Core Lab, Pennsylvania State College of Medicine, Hershey, PA, United States
  • 7Centre for Comparative Medicine, University of British Columbia, Vancouver, BC, Canada
  • 8Department of Chemistry, University of British Columbia, Vancouver, BC, Canada
  • 9Bioasis Technologies Inc., Guilford, CT, United States
  • 10King's College London, London, United Kingdom
  • 11Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada
  • 12Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada
  • 13Department of Zoology, University of British Columbia, Vancouver, BC, Canada

A Corrigendum on
A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke

by Eyford, B. A., Singh, C. S. B., Abraham, T., Munro, L., Choi, K. B., Hill, T., et al. (2021). Front. Mol. Biosci. 8:611367. doi: 10.3389/fmolb.2021.611367

In the original article, there was an error in the Funding statement. “MT” should be removed from “BTI MT.” The corrected Funding statement should read:

“Funding for this work was provided to WJ in the Michael Smith Laboratories, at the University of British Columbia and the Vancouver Prostate Centre, at Vancouver General Hospital, by a grant from the Canadian Institutes for Health Research (MOP-133635), a grant from the Natural Sciences and Engineering Research Council of Canada (CRDPJ 452456–13) in collaboration with Bioasis Technologies Inc. (BTI, bWVpbWVpQGJpb2FzaXMudXM=), a grant from the W. Garfield Weston Foundation (RR161038), and donations from the Sullivan Urology Foundation at Vancouver General Hospital. TA was supported by NIH grants 1S10OD010756–01A1 and 1S10OD018124–01A1. BE was supported by Postdoctoral Fellowships from the Michael Smith Foundation for Health Research, the Centre for Blood Research at the University of British Columbia and the Pacific Alzheimer's Foundation. CS was supported by an Alzheimer's Drug Discovery Foundation Outstanding Young Investigator Scholarship, and by a William and Dorothy Gilbert Graduate Scholarship in Biomedical Sciences at the University of British Columbia and a scholarship from the Centre for Blood Research Graduate Student Award at the University of British Columbia.”

Additionally, there was a mistake in the COI section, which should now read:

“The authors declare that this study received funding from Bioasis Technologies Inc. The funder did not influence the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.”

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: stroke, peptide-oligonucleotide conjugate, MTfp, blood-brain barrier, NOX4, siRNA

Citation: Eyford BA, Singh CSB, Abraham T, Munro L, Choi KB, Hill T, Hildebrandt R, Welch I, Vitalis TZ, Gabathuler R, Gordon JA, Adomat H, Guns ES, Lu C-J, Pfeifer CG, Tian MM and Jefferies WA (2021) Corrigendum: A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke. Front. Mol. Biosci. 8:687587. doi: 10.3389/fmolb.2021.687587

Received: 29 March 2021; Accepted: 30 March 2021;
Published: 07 May 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Eyford, Singh, Abraham, Munro, Choi, Hill, Hildebrandt, Welch, Vitalis, Gabathuler, Gordon, Adomat, Guns, Lu, Pfeifer, Tian and Jefferies. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Wilfred A. Jefferies, d2lsZkBtc2wudWJjLmNh

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more